Literature DB >> 19002727

A portrait of Staphylococcus aureus from the other side of the Mediterranean Sea: molecular characteristics of isolates from Western Algeria.

S N Bekkhoucha1, A Cady, P Gautier, F Itim, P-Y Donnio.   

Abstract

Algerian hospitals have experienced a dramatic increase in methicillin-resistant Staphylococcus aureus (MRSA) prevalence in recent years. To investigate this phenomenon, we have determined molecular characteristics of 61 methicillin-resistant or -susceptible strains isolated between 2003 and 2007 in Oran Hospital. Susceptible isolates were related to diverse genetic backgrounds, of which clone with sequence type (ST) 8 accounted for most of the samples. Resistance to methicillin was almost limited to two international spreading clones; the most frequent, ST80, contained isolates producing Panton-Valentine leukocidine, with SCCmec type IV. The increase of MRSA prevalence observed in Western Algeria, in outpatients as well as in hospitalized patients, is linked to dissemination of ST80 strains usually considered as community-acquired MRSA.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19002727     DOI： 10.1007/s10096-008-0660-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  10 in total

1.  Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus.

Authors:  Duarte C Oliveira; Hermínia de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection.

Authors:  Nuno A Faria; Duarte C Oliveira; Henrik Westh; Dominique L Monnet; Anders R Larsen; Robert Skov; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital.

Authors:  Nadjia Ramdani-Bouguessa; Michèle Bes; Hélène Meugnier; Françoise Forey; Marie-Elisabeth Reverdy; Gerard Lina; François Vandenesch; Mohamed Tazir; Jerome Etienne
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

4.  Characterization of ST80 Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone in Tunisia.

Authors:  Mouna Ben Nejma; Maha Mastouri; Besma Bel Hadj Jrad; Mohamed Nour
Journal:  Diagn Microbiol Infect Dis       Date:  2008-04-03       Impact factor: 2.803

5.  Comparison of genetic backgrounds of methicillin-resistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community.

Authors:  M Aires de Sousa; T Conceição; C Simas; H de Lencastre
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta.

Authors:  C Kesah; S Ben Redjeb; T O Odugbemi; C S-B Boye; M Dosso; J O Ndinya Achola; S Koulla-Shiro; M Benbachir; K Rahal; M Borg
Journal:  Clin Microbiol Infect       Date:  2003-02       Impact factor: 8.067

7.  Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains.

Authors:  B Shopsin; M Gomez; S O Montgomery; D H Smith; M Waddington; D E Dodge; D A Bost; M Riehman; S Naidich; B N Kreiswirth
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

8.  Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries.

Authors:  Michael A Borg; Marlieke de Kraker; Elizabeth Scicluna; Nienke van de Sande-Bruinsma; Edine Tiemersma; Jos Monen; Hajo Grundmann
Journal:  J Antimicrob Chemother       Date:  2007-10-02       Impact factor: 5.790

9.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.

Authors:  M C Enright; N P Day; C E Davies; S J Peacock; B G Spratt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

10.  Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.

Authors:  Anne Tristan; Michele Bes; Helene Meugnier; Gerard Lina; Bülent Bozdogan; Patrice Courvalin; Marie-Elisabeth Reverdy; Mark C Enright; François Vandenesch; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883
  10 in total
  18 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  High levels of Staphylococcus aureus and MRSA carriage in healthy population of Algiers revealed by additional enrichment and multisite screening.

Authors:  Kenza Antri; Madjid Akkou; Coralie Bouchiat; Michèle Bes; Patricia Martins-Simoes; Olivier Dauwalder; Anne Tristan; Hélène Meugnier; Jean-Philippe Rasigade; Jerome Etienne; François Vandenesch; Frédéric Laurent; Nadjia Ramdani-Bouguessa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-12       Impact factor: 3.267

Review 3.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

4.  Characterisation of MRSA strains isolated from patients in a hospital in Riyadh, Kingdom of Saudi Arabia.

Authors:  Stefan Monecke; Leila Skakni; Rami Hasan; Antje Ruppelt; Sameeh S Ghazal; Ahmed Hakawi; Peter Slickers; Ralf Ehricht
Journal:  BMC Microbiol       Date:  2012-07-23       Impact factor: 3.605

5.  Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region.

Authors:  Geoffrey W Coombs; Stefan Monecke; Julie C Pearson; Hui-leen Tan; Yi-Kong Chew; Lynne Wilson; Ralf Ehricht; Frances G O'Brien; Keryn J Christiansen
Journal:  BMC Microbiol       Date:  2011-09-29       Impact factor: 3.605

6.  A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus.

Authors:  Stefan Monecke; Geoffrey Coombs; Anna C Shore; David C Coleman; Patrick Akpaka; Michael Borg; Henry Chow; Margaret Ip; Lutz Jatzwauk; Daniel Jonas; Kristina Kadlec; Angela Kearns; Frederic Laurent; Frances G O'Brien; Julie Pearson; Antje Ruppelt; Stefan Schwarz; Elizabeth Scicluna; Peter Slickers; Hui-Leen Tan; Stefan Weber; Ralf Ehricht
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

7.  Clonal replacement of epidemic methicillin-resistant Staphylococcus aureus strains in a German university hospital over a period of eleven years.

Authors:  Nicole Albrecht; Lutz Jatzwauk; Peter Slickers; Ralf Ehricht; Stefan Monecke
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

8.  Molecular typing of MRSA and of clinical Staphylococcus aureus isolates from Iaşi, Romania.

Authors:  Stefan Monecke; Elke Müller; Olivia Simona Dorneanu; Teodora Vremeră; Ralf Ehricht
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

9.  The molecular epidemiology of the highly virulent ST93 Australian community Staphylococcus aureus strain.

Authors:  Geoffrey W Coombs; Richard V Goering; Kyra Y L Chua; Stefan Monecke; Benjamin P Howden; Timothy P Stinear; Ralf Ehricht; Frances G O'Brien; Keryn J Christiansen
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

10.  Molecular epidemiology and antimicrobial susceptibility of clinical Staphylococcus aureus from healthcare institutions in Ghana.

Authors:  Beverly Egyir; Luca Guardabassi; Marit Sørum; Søren Saxmose Nielsen; Augusta Kolekang; Enoch Frimpong; Kennedy Kwasi Addo; Mercy Jemima Newman; Anders Rhod Larsen
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.